Vanguard Group Inc. Has $189.16 Million Stake in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)

Vanguard Group Inc. increased its position in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 1.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,824,640 shares of the software maker’s stock after buying an additional 181,721 shares during the quarter. Vanguard Group Inc. owned 8.17% of Allscripts Healthcare Solutions worth $189,162,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. World Asset Management Inc increased its stake in shares of Allscripts Healthcare Solutions by 0.7% in the second quarter. World Asset Management Inc now owns 11,419 shares of the software maker’s stock worth $146,000 after buying an additional 81 shares during the period. Advantus Capital Management Inc boosted its holdings in Allscripts Healthcare Solutions by 0.5% in the first quarter. Advantus Capital Management Inc now owns 23,112 shares of the software maker’s stock valued at $293,000 after acquiring an additional 109 shares in the last quarter. Atlantic Trust Group LLC boosted its holdings in Allscripts Healthcare Solutions by 0.3% in the second quarter. Atlantic Trust Group LLC now owns 32,900 shares of the software maker’s stock valued at $420,000 after acquiring an additional 110 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in Allscripts Healthcare Solutions by 0.4% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 26,484 shares of the software maker’s stock valued at $338,000 after acquiring an additional 115 shares in the last quarter. Finally, Bank of Montreal Can boosted its holdings in Allscripts Healthcare Solutions by 6.9% in the second quarter. Bank of Montreal Can now owns 10,603 shares of the software maker’s stock valued at $135,000 after acquiring an additional 689 shares in the last quarter.

MDRX has been the topic of a number of research reports. Dougherty & Co restated a “buy” rating and set a $16.00 target price (up previously from $15.00) on shares of Allscripts Healthcare Solutions in a report on Tuesday, October 3rd. Cantor Fitzgerald restated a “buy” rating and set a $17.00 target price on shares of Allscripts Healthcare Solutions in a report on Wednesday, September 27th. Jefferies Group LLC set a $17.00 target price on shares of Allscripts Healthcare Solutions and gave the company a “buy” rating in a report on Friday, August 25th. Maxim Group restated a “buy” rating and set a $16.00 target price on shares of Allscripts Healthcare Solutions in a report on Friday, August 4th. Finally, Robert W. Baird reaffirmed a “buy” rating and issued a $16.00 price target on shares of Allscripts Healthcare Solutions in a research report on Tuesday, October 17th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and eleven have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $15.00.

TRADEMARK VIOLATION WARNING: This piece was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another website, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2017/10/27/vanguard-group-inc-acquires-181721-shares-of-allscripts-healthcare-solutions-inc-mdrx.html.

In related news, CEO Paul Black sold 15,000 shares of Allscripts Healthcare Solutions stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $13.52, for a total value of $202,800.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Brian Farley sold 5,000 shares of Allscripts Healthcare Solutions stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $13.52, for a total value of $67,600.00. Following the completion of the transaction, the executive vice president now owns 196,607 shares in the company, valued at approximately $2,658,126.64. The disclosure for this sale can be found here. Insiders have sold 35,000 shares of company stock worth $473,800 in the last 90 days. Insiders own 0.75% of the company’s stock.

Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ MDRX) opened at 13.57 on Friday. The company’s 50-day moving average price is $13.87 and its 200-day moving average price is $12.74. Allscripts Healthcare Solutions, Inc. has a 12 month low of $9.80 and a 12 month high of $14.45. The company’s market cap is $2.45 billion.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.04). Allscripts Healthcare Solutions had a positive return on equity of 5.97% and a negative net margin of 11.54%. The business had revenue of $426.10 million for the quarter, compared to analyst estimates of $424.94 million. During the same quarter last year, the business earned $0.14 EPS. Allscripts Healthcare Solutions’s revenue for the quarter was up 10.2% compared to the same quarter last year. Equities analysts forecast that Allscripts Healthcare Solutions, Inc. will post $0.61 EPS for the current fiscal year.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply